Stifel analyst Benjamin Nolan reiterated a Sell rating on Tellurian (NASDAQ: TELL) after the company announced a 3 mtpa SPA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE